Latest Breaking News On - Wasatch advisors inc - Page 5 : comparemela.com

DLocal (NASDAQ:DLO) Price Target Cut to $17 00

DLocal (NASDAQ:DLO) Price Target Cut to $17 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Millennium managementWasatch advisors incEventide asset managementGoldman sachs groupJpmorgan chase coAlkeon capital managementDlocal company profileFree reportStreet researchCapital managementAsset managementMangrove partnersGet free report

Castle Biosciences, Inc (NASDAQ:CSTL) Director Daniel Bradbury Sells 9,152 Shares

Castle Biosciences, Inc (NASDAQ:CSTL) Director Daniel Bradbury Sells 9,152 Shares
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Castle biosciencesDaniel bradburyPrincipal financial group incBlackrock incVanguard group incSecurities exchange commissionCastle biosciences company profileCastle biosciences incBellevue groupWasatch advisors incGet free reportDirector daniel bradburyExchange commissionFinancial groupMypath melanomaCastle biosciences daily

Wakefield Asset Management LLLP Has $1 11 Million Stock Holdings in Medpace Holdings, Inc (NASDAQ:MEDP)

Wakefield Asset Management LLLP lifted its stake in shares of Medpace Holdings, Inc. (NASDAQ:MEDP – Free Report) by 10.8% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 3,607 shares of the company’s stock after buying an additional 351 shares during the quarter. Wakefield Asset Management LLLP’s holdings in Medpace were worth $1,106,000 as […]

United statesAshleym keatingAugustj troendleRobertw bairdBlackrock incRiverbridge partnersMedpace company profileMedpace holdings incDeutsche bank aktiengesellschaftWasatch advisors incDimensional fund advisorsWakefield asset managementMedpace holdingsFree reportAsset managementStreet corp

Five Below (NASDAQ:FIVE) Cut to Accumulate at Gordon Haskett

Gordon Haskett lowered shares of Five Below (NASDAQ:FIVE – Free Report) from a buy rating to an accumulate rating in a research report released on Wednesday, Marketbeat reports. They currently have $200.00 price target on the specialty retailer’s stock, down from their prior price target of $210.00. Several other research firms have also commented on […]

United statesGordon haskettThomas velliosMorgan stanleyPricet rowe associates incMontrusco bolton investments incBelow incSecurities exchange commissionWasatch advisors incWilliam blair investment managementFive belowFree reportModerate buyGet free reportDirector thomas velliosExchange commission

Tritonpoint Wealth LLC Invests $2 04 Million in Castle Biosciences, Inc (NASDAQ:CSTL)

Tritonpoint Wealth LLC Invests $2 04 Million in Castle Biosciences, Inc (NASDAQ:CSTL)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Castle biosciencesDerekj maetzoldInvesco ltdBlackrock incWasatch advisors incPrincipal financial group incTritonpoint wealthVanguard group incCastle biosciences incFree reportFinancial groupGet free reportMypath melanomaVisit holdingschannelCastle biosciences daily